drugset / Trial / NCT05665777

Chinese Medicine for Treating Chronic Pharyngolaryngitis

NCT05665777 ↗

Phase 2 Unknown 74 enrolled Chinese University of Hong Kong
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine formula in treating Chronic pharyngolaryngitis. Subjects will be randomized into a treatment group or placebo group for 8 weeks, and then followed by an 8-week post-treatment visit.

Timeline

Start
2023-03-30
Primary completion
2025-01-31
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Qingyan Lihou Decoction Traditional medicine (herbal / TCM) — Oral